GlassScriptPhysician profile
Mindi Fry
NPI 1447560669
$4,700.35
in general payments reported to CMS, 2019-2025
36 companies · $1,286 in 2025
The $1,286 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $329 · 2022: $479 · 2023: $971 · 2024: $1,635 · 2025: $1,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,875 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,874.71 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $733.58 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $402.14 | 2023-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Heartflow, INC. | $343.50 | 2023-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $306.03 | 2022-2025 | Farxiga, Lokelma, Andexxa |
| Abbott Laboratories | $279.59 | 2021-2023 | Ensite Precision, Cardiomems, Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $247.53 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $234.50 | 2022-2025 | |
| Medtronic, INC. | $228.42 | 2021-2024 | Na, Ffrangio, Micra |
| Esperion Therapeutics, INC. | $169.82 | 2021 | |
| Amgen INC. | $162.72 | 2022-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $137.08 | 2023-2025 | |
| Abiomed | $133.72 | 2024-2025 | Impella |
| Impulse Dynamics (USA) INC. | $103.95 | 2023 | Optimizer |
| Philips North America LLC | $102.22 | 2023-2025 | (5044) Mcot, Mcot |
| Pfizer INC. | $93.35 | 2023-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $89.42 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Novo Nordisk INC | $88.36 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Alnylam Pharmaceuticals INC. | $83.31 | 2024-2025 | Onpattro, Amvuttra |
| Cardiva Medical, INC. | $83.17 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bayer Healthcare Pharmaceuticals INC. | $80.22 | 2022-2025 | |
| Cvrx, INC. | $79.88 | 2025 | Barostim Neo System |
| Medicomp INC | $78.81 | 2022-2024 | Telepatch Cardiac Monitor |
| Biosense Webster, INC. | $60.31 | 2025 | Carto 3, Nuvision Ice Catheter |
| Merck Sharp & Dohme LLC | $56.98 | 2022-2025 | Verquvo |
| Lilly USA, LLC | $51.85 | 2025 | Zepbound |
| Actelion Pharmaceuticals US, INC. | $43.05 | 2021 | |
| Bracco Diagnostics INC. | $33.69 | 2024 | |
| Sanofi-Aventis U.S. LLC | $27.44 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $23.58 | 2024 | Evkeeza |
| Janssen Pharmaceuticals, INC | $23.51 | 2024 | Xarelto |
| Irhythm Technologies, INC. | $23.27 | 2023 | Zio Xt Patch |
| Kestra Medical Technology Services, INC. | $23.14 | 2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $22.71 | 2025 | Attruby |
| Amarin Pharma, INC. | $18.37 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $17.20 | 2021 | |
| Altathera Pharmaceuticals LLC | $13.93 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindi Fry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.